Overview
Mitchell Binder is a Hematologist Oncology specialist and a Hematologist in Rio Rancho, New Mexico. Dr. Binder is rated as an Experienced provider by MediFind in the treatment of Hereditary Spherocytosis. His top areas of expertise are Squamous Cell Lung Carcinoma, Large-Cell Lung Carcinoma, Lung Adenocarcinoma, and Non-Small Cell Lung Cancer (NSCLC). Dr. Binder is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2400 Unser Blvd Se, Rio Rancho, NM 87124
2200 W 21st St, Clovis, NM 88101
Richard Lauer is a Hematologist Oncology specialist and a Hematologist in Albuquerque, New Mexico. Dr. Lauer is rated as an Advanced provider by MediFind in the treatment of Hereditary Spherocytosis. His top areas of expertise are Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Multiple Myeloma, and Prostate Cancer.
Presbyterian Healthcare Services
Kenneth Smith is a Hematologist in Albuquerque, New Mexico. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Hereditary Spherocytosis. His top areas of expertise are Essential Thrombocythemia, Acute Mountain Sickness, Schnitzler Syndrome, and Monoclonal Gammopathy of Undetermined Significance (MGUS).
Nexus Health
David Snyder is a Hematologist Oncology specialist and an Oncologist in Santa Fe, New Mexico. Dr. Snyder is rated as a Distinguished provider by MediFind in the treatment of Hereditary Spherocytosis. His top areas of expertise are Pleuropulmonary Blastoma, Common Variable Immune Deficiency, Lung Cancer, and Colorectal Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Binder isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Binder isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Binder isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Binder isDistinguished. Learn about Lung Adenocarcinoma.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Binder isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Small Cell Lung Cancer (SCLC)Dr. Binder isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- Acute Mountain SicknessDr. Binder isAdvanced. Learn about Acute Mountain Sickness.
- AngiosarcomaDr. Binder isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Binder isAdvanced. Learn about Breast Cancer.
- Dendritic Cell TumorDr. Binder isAdvanced. Learn about Dendritic Cell Tumor.
- Essential ThrombocythemiaDr. Binder isAdvanced. Learn about Essential Thrombocythemia.
- Inflammatory Breast CancerDr. Binder isAdvanced. Learn about Inflammatory Breast Cancer.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Binder isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Binder isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Binder isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Binder isExperienced. Learn about Agranulocytosis.